Auris Medical Cash Flow - Annual (NASDAQ:EARS)

Add to My Stocks
$0.29 $0 (0%) EARS stock closing price Sep 18, 2018 (Closing)

The Auris Medical cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the Auris Medical debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Auris Medical revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Auris Medical stock analysis. Auris Medical generated $-24.67M cash from operating activities in 2017. EARS decrease in investments stood at a value of $-0.1M for the latest year 2017.

View details of Auris Medical cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2017201620152014
Net Income Cash Flow
-24.8M-31.13M-28.55M-19.9M
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities-0.47M-1.6M2.85M
Cash From (used in) Discontinued Operations----
Other Adjustments Net---0.75M-4.17M
Net Cash from (used by) Operating Activities
-24.67M-29.9M-27.61M-21.13M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.24M-0.07M-1.29M
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities-0.09M---
Net Cash from (used by) Investment Activities
-0.1M-0.17M-0.04M-1.29M
Issuance (Purchase) of Equity Shares13.25M-20.31M-
Issuance (Repayment) of Debt Securities-2.12M12.17M--
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-2.77M-0.55M-0.2M54M
Net Cash from (used by) Financing Activities
8.35M11.61M20.1M54.28M
Effect of Exchange Rate Changes on Cash-1.33M-1.1M4.33M
Net Change in Cash & Cash Equivalents
-17.75M-18.06M-6.43M36.18M
Cash & Equivalents at Beginning of Year32.97M51M54.73M26.11M
Cash & Equivalents at Year End15.21M32.93M48.29M62.3M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Auris Medical stock price history and Auris Medical stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Auris Medical is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Auris Medical stock price movement.
  • The cash generated from the core business or operations was a negative at $-24.67M for Auris Medical in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash from investing stood at a negative value of $-0.1M for EARS stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Auris Medical earned $8.35M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Auris Medical Cash Flow